ONWARD Medical
ONWARD Medical is a neurotechnology company pioneering therapies to restore movement, function, and independence in people living with spinal cord injuries through innovative spinal cord stimulation platforms including the FDA-cleared ARC-EX System.
Company facts
- Founded
- 2014
- Headquarters
- Netherlands
- CEO
- Dave Marver
About
ONWARD Medical is a medical technology company dedicated to creating therapies that restore movement, function, and independence for people with spinal cord injury (SCI). The company develops innovative neurostimulation systems, including ARC Therapy platforms such as ARC-EX (FDA-cleared non-invasive spinal cord stimulation) and ARC-IM (investigational implantable spinal cord stimulation), as well as brain-computer interface (BCI) technologies. Headquartered in Eindhoven, the Netherlands, ONWARD Medical brings together a multidisciplinary team of scientists, engineers, and physicians committed to advancing neurotechnology. The company has received 10 FDA Breakthrough Device Designation awards and holds nearly 400 issued or pending patents. Their ARC-EX System is the first FDA-cleared technology indicated to improve hand sensation and strength in people with chronic incomplete cervical spinal cord injury. ONWARD Medical trades on Euronext Amsterdam under the ticker ONWD and has raised significant funding including over EUR 40 million in recent capital raises to support commercial expansion and continued technology development.